Skip to main content
. 2018 Aug 6;19(12):1102–1107. doi: 10.1080/15384047.2018.1491501
Nasopharyngeal carcinoma NPC
National Comprehensive Cancer Network NCCN
locoregionally advanced NPC LA-NPC
concurrent chemoradiotherapy CCRT
epidermal growth factor receptor EGFR
nimotuzumab NTZ
American Joint Committee on Cancer AJCC
progression-free survival PFS
locoregional relapse-free survival LRRFS
overall survival OS
distant metastasis-free survival DMFS.